We recently reported that the inhibition of KCa1.1 overcame chemoresistance by down-regulating drug-metabolizing enzymes through the Akt-Nrf2 signaling pathway in 3D cancer spheroid models [2]. This evidence concerns the gene NFE2L2 and cancer.